MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary


Drug Safety Update

November 2023: Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir

NICE Guidance

NG191: COVID-19 rapid guideline: managing COVID-19. Last updated June 2023.

TA878: Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19. Last updated June 2023. (Note that Casirivimab plus imdevimab is NOT recommended for treating acute COVID‑19 in adults in this TA)